Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imukin in steroid-refractory bronchiolitis obliterans after allogeneic SCT
NCT01639261Phase 2Unknown
- Sponsor
- Universitätsklinikum Regensburg
- Start
- Jul 2012
- Primary completion
- Dec 2013
- Countries
- 1
01
Overview
A Phase 2 trial of interferon gamma-1b in Bronchiolitis Obliterans (BO), sponsored by Universitätsklinikum Regensburg. Status: unknown.
02
Drugs
interferon gamma-1b
03
Conditions
Bronchiolitis Obliterans (BO)
Beyond the preview
Go deeper on NCT01639261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01639261.